Last week, Heather Bresch, the CEO of Mylan Pharmaceuticals, testified in front of Congress about why the company has raised the price of EpiPen from roughly $57 in 2007 to $600 today. Under intense questioning, she claimed that the company only makes about $100 per 2-pack of EpiPens. Today the company was forced to “clarify” that the price was actually higher. They make $160.
Bresch spent a good deal of her time testifying last week by explaining that even though the price of the EpiPen is $600, that entire price doesn’t go straight to Mylan. It was a rather offensive and obtuse show, with Bresch attempting to explain that those who distribute and manufacture the product also get a cut. But Congress, much like the public, were curious just how much of that money was going straight in Mylan’s pocket. Bresch said it was just $100. Which was a lie. – READ MORE
